Nanotechnology in vascular medicine a review
International Journal of Development Research
Nanotechnology in vascular medicine a review
Received 03rd May, 2021; Received in revised form 11th June, 2021; Accepted 16th July, 2021; Published online 26th August, 2021
Copyright © 2021, Mirzaie Masoud et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Although the application of materials produced in nanotechnology with a size of 1-100 nm in at least one of their dimensions at the molecular level opens new perspectives in the care of patients, the question of cost-effectiveness and the safety of nanotechnology still remain open. These have proven to be useful not only as prosthetic materials, but also for surface preparation of implants and prostheses, effective drug delivery systems for antibiotics, and chemotherapeutics, and drug eluting systems to combat implant-related infections, e.g.. The application of nanotechnology in vascular medicine firstly extends to both drug-eluting therapies for obstructive vascular diseases and prosthetic materials used for surgical revascularization. The novel nanomaterials can deliver the thrombolytic drugs directly to the lesion.
